{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T19:11:57Z","timestamp":1782587517538,"version":"3.54.5"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001563","name":"Otago Medical Research Foundation","doi-asserted-by":"publisher","award":["Laurenson Award"],"award-info":[{"award-number":["Laurenson Award"]}],"id":[{"id":"10.13039\/501100001563","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Healthcare Otago"},{"DOI":"10.13039\/501100009477","name":"Lottery Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009477","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0220837","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T17:24:27Z","timestamp":1565630667000},"page":"e0220837","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Myocardial global longitudinal strain: An early indicator of cardiac interstitial fibrosis modified by spironolactone, in a unique hypertensive rat model"],"prefix":"10.1371","volume":"14","author":[{"given":"Catherine J.","family":"Leader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Moharram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2312-4666","authenticated-orcid":true,"given":"Sean","family":"Coffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan A.","family":"Sammut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard W.","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3366-0956","authenticated-orcid":true,"given":"Robert J.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,8,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.113.02149","article-title":"Left ventricular strain and transmural distribution of structural remodeling in hypertensive heart disease","volume":"63","author":"T Ishizu","year":"2014","journal-title":"Hypertension"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jacbts.2017.07.013","article-title":"Murine Models of Heart Failure With Preserved Ejection Fraction: A \u201cFishing Expedition.\u201d","volume":"2","author":"M Valero-Mu\u00f1oz","year":"2017","journal-title":"JACC. Basic to Transl. Sci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/hrt.2004.042473","article-title":"Left ventricular hypertrophy in hypertension: Its arrhythmogenic potential","volume":"91","author":"T Kahan","year":"2005","journal-title":"Heart"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5494\/wjh.v5.i2.41","article-title":"Hypertensive cardiomyopathy: A clinical approach and literature review","volume":"5","author":"K Kuroda","year":"2015","journal-title":"World J. Hypertens"},{"key":"ref5","first-page":"1580","article-title":"Surrogate Survival. Battle Between Left Ventricular Ejection Fraction and Global Longitudinal Strain","volume":"11","author":"GA Whalley","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"H1371","DOI":"10.1152\/ajpheart.00553.2013","article-title":"High-frequency speckle tracking echocardiography in the assessment of left ventricular function and remodeling after murine myocardial infarction","volume":"306","author":"A Bhan","year":"2014","journal-title":"AJP Heart. Circ. Physiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1161\/CIRCRESAHA.110.239574","article-title":"Echocardiographic speckle-tracking based strain imaging for rapid cardiovascular phenotyping in mice","volume":"108","author":"M Bauer","year":"2011","journal-title":"Circ. Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-017-0645-0","article-title":"Comparison of speckle-tracking echocardiography with invasive hemodynamics for the detection of characteristic cardiac dysfunction in type-1 and type-2 diabetic rat models","volume":"17","author":"C M\u00e1ty\u00e1s","year":"2018","journal-title":"Cardiovasc. Diabetol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.echo.2012.11.015","article-title":"Longitudinal strain impairment as a marker of the progression of heart failure with preserved ejection fraction in a rat model","volume":"26","author":"R Koshizuka","year":"2013","journal-title":"J. Am. Soc. Echocardiogr"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10741-012-9305-3","article-title":"Rodent models of heart failure: An updated review","volume":"18","author":"AC Gomes","year":"2013","journal-title":"Heart Fail. Rev"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1469-445X.2000.02096.x","article-title":"Transgenic animals in cardiovascular disease research","volume":"85","author":"M Bader","year":"2000","journal-title":"Exp. Physiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"36727","DOI":"10.1074\/jbc.M103296200","article-title":"Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease","volume":"276","author":"S Kantachuvesiri","year":"2001","journal-title":"J Biol. Chem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3317\/jraas.2006.013","article-title":"Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats","volume":"7","author":"KD Mitchell","year":"2006","journal-title":"J. Renin-Angiotensin-Aldosterone Syst"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"F52","DOI":"10.1152\/ajprenal.00187.2011","article-title":"Renal functional responses to selective intrarenal renin inhibition in Cyp1a1-Ren2 transgenic rats with ANG II-dependent malignant hypertension","volume":"302","author":"CG Howard","year":"2012","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1582-4934.2009.00778.x","article-title":"The renin-angiotensin system as a primary cause of polyarteritis nodosa in rats","volume":"14","author":"BS Peters","year":"2010","journal-title":"J. Cell. Mol. Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/MAJ.0b013e3181d82a62","article-title":"Transient induction of ANG II-dependent malignant hypertension causes sustained elevation of blood pressure and augmentation of the pressor response to ANG II in CYP1A1-REN2 transgenic rats","volume":"339","author":"CG Howard","year":"2010","journal-title":"Am. J. Med. Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/HJH.0b013e3282f0ab66","article-title":"Dose-dependent titration of prorenin and blood pressure in Cyp1a1ren-2 transgenic rats: absence of prorenin-induced glomerulosclerosis","volume":"26","author":"B Peters","year":"2008","journal-title":"J. Hypertens"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.30802\/AALAS-CM-17-18000026","article-title":"Transgenic Cyp1a1Ren2 rats (TG[Cyp1a1Ren2]): Breeding characteristics and dose-dependant blood pressure responses","volume":"68","author":"C Leader","year":"2018","journal-title":"Comp. Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"12A","DOI":"10.1016\/0002-9149(93)90239-9","article-title":"Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension","volume":"71","author":"CG Brilla","year":"1993","journal-title":"Am. J. Cardiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0735-1097(00)01129-3","article-title":"Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats","volume":"37","author":"P Lacolley","year":"2001","journal-title":"J. Am. Coll. Cardiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/jce.12379","article-title":"Eplerenone-Mediated Regression of Electrical Activation Delays and Myocardial Fibrosis in Heart Failure","volume":"25","author":"C Tanaka-Esposito","year":"2014","journal-title":"J. Cardiovasc. Electrophysiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S1734-1140(11)70613-2","article-title":"Long-term use of low-dose spironolactone in spontaneously hypertensive rats: effects on left ventricular hypertrophy and stiffness","volume":"63","author":"MP Baldo","year":"2011","journal-title":"Pharmacol. Rep"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/eurheartj\/ehn277","article-title":"Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: A comparison with spironolactone","volume":"29","author":"P Mulder","year":"2008","journal-title":"Eur. Heart J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.yjmcc.2005.05.002","article-title":"Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogen","volume":"39","author":"A Lal","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for Heart Failure with Preserved Ejection Fraction","volume":"370","author":"B Pitt","year":"2014","journal-title":"N. Engl. J. Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0002-9149(96)00465-1","article-title":"Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES])","volume":"78","year":"1996","journal-title":"Am. J. Cardiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/HYPERTENSIONAHA.117.10662","article-title":"Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension","volume":"71","author":"EM Krieger","year":"2018","journal-title":"Hypertension"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1161\/CIRCULATIONAHA.115.015884","article-title":"Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone","volume":"132","author":"AM Shah","year":"2015","journal-title":"Circulation"},{"key":"ref29","first-page":"50","article-title":"Aldosterone and aldosterone antagonists in cardiac disease: what is known, what is new","volume":"2","author":"C Catena","year":"2011","journal-title":"Am. J. Cardiovasc. Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0b013e3283599b6a","article-title":"Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension","volume":"31","author":"G Colussi","year":"2012","journal-title":"J. Hypertens"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11886-014-0545-9","article-title":"Current Perspectives on Systemic Hypertension in Heart Failure with Preserved Ejection Fraction","volume":"16","author":"AA Oktay","year":"2014","journal-title":"Curr. Cardiol. Rep"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/clc.22025","article-title":"Aldosterone receptor antagonists in cardiovascular disease: A review of the recent literature and insight into potential future indications","volume":"35","author":"M Markowitz","year":"2012","journal-title":"Clin. Cardiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2017.00313","article-title":"Mineralocorticoid receptor signaling as a therapeutic target for renal and cardiac fibrosis","volume":"8","author":"GH Tesch","year":"2017","journal-title":"Front. Pharmacol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","article-title":"Mineralocorticoid blockage reduces vascular injury in stroke-prone hypertensive rats","volume":"31","author":"R Rocha","year":"1998","journal-title":"Hypertension"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.HYP.0000203772.78696.67","article-title":"Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats","volume":"47","author":"K Nagata","year":"2006","journal-title":"Hypertension"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.mce.2011.06.038","article-title":"Aldosterone, mineralocorticoid receptor, and heart failure","volume":"350","author":"S Messaoudi","year":"2012","journal-title":"Mol. Cell. Endocrinol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrneph.2010.30","article-title":"Aldosterone: effects on the kidney and cardiovascular system","volume":"6","author":"M Briet","year":"2010","journal-title":"Nat. Rev. Nephrol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s11906-008-0041-y","article-title":"Mineralocorticoid antagonism and cardiac hypertrophy","volume":"10","author":"K Nagata","year":"2008","journal-title":"Curr. Hypertens. Rep"},{"key":"ref39","first-page":"1","article-title":"Animal Welfare Act 1999","year":"1999"},{"key":"ref40","first-page":"659","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"S Reagan-shaw","year":"2008","journal-title":"J. Fed. Am. Soc. Exp. Biol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjci\/jeu184","article-title":"Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging","volume":"16","author":"JU Voigt","year":"2015","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/CIRCIMAGING.109.862334","article-title":"Prediction of all-cause mortality from global longitudinal speckle strain: Comparison with ejection fraction and wall motion scoring","volume":"2","author":"T Stanton","year":"2009","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1136\/heartjnl-2014-305538","article-title":"Prognostic implications of global LV dysfunction: A systematic review and meta-analysis of global longitudinal strain and ejection fraction","volume":"100","author":"K Kalam","year":"2014","journal-title":"Heart"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e0127044","DOI":"10.1371\/journal.pone.0127044","article-title":"Left Ventricular Global Longitudinal Strain (GLS) Is a Superior Predictor of All-Cause and Cardiovascular Mortality When Compared to Ejection Fraction in Advanced Chronic Kidney Disease","volume":"10","author":"R Krishnasamy","year":"2015","journal-title":"PLoS One"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jacc.2017.06.046","article-title":"Geometry as a Confounder When Assessing Ventricular Systolic Function: Comparison Between Ejection Fraction and Strain","volume":"70","author":"TM Stokke","year":"2017","journal-title":"J. Am. Coll. Cardiol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.jcmg.2017.08.023","article-title":"2D and 3D Echocardiography-Derived Indices of Left Ventricular Function and Shape: Relationship With Mortality","volume":"11","author":"D Medvedofsky","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"H664","DOI":"10.1152\/ajpheart.00017.2010","article-title":"Layer-specific strain analysis by speckle tracking echocardiography reveals differences in left ventricular function between rats and humans","volume":"299","author":"N Bachner-Hinenzon","year":"2010","journal-title":"Am. J Physiol. Hear. Circ. Physiol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system","volume":"83","author":"KT Weber","year":"1991","journal-title":"Circulation"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0008-6363(97)00097-7","article-title":"Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion","volume":"35","author":"Y Sun","year":"1997","journal-title":"Cardiovasc. Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/01.RES.74.4.727","article-title":"Angiotensin II Induces Fibronectin Expression Associated With Cardiac Fibrosis in the Rat","volume":"74","author":"DC Crawford","year":"1994","journal-title":"Circ. Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-Induced Inflammation in the Rat Heart","volume":"161","author":"Y Sun","year":"2002","journal-title":"Am. J. Pathol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1172\/JCI117269","article-title":"Mineralocorticoids, hypertension, and cardiac fibrosis","volume":"93","author":"M Young","year":"1994","journal-title":"Jounral Clin. Investig"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1161\/01.HYP.23.6.869","article-title":"Structural remodeling in hypertensive heart disease and the role of hormones","volume":"23","author":"KT Weber","year":"1994","journal-title":"Hypertension"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism","volume":"25","author":"CG Brilla","year":"1993","journal-title":"J. Mol. Cell. Cardiol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.HYP.24.1.30","article-title":"Increased Cardiac Types I and III Collagen mRNAs in Aldosterone-Salt Hypertension","volume":"24","author":"V Robert","year":"1994","journal-title":"Hypertension"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/HYPERTENSIONAHA.114.04488","article-title":"Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases","volume":"65","author":"J Bauersachs","year":"2015","journal-title":"Hypertension"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0025-7125(03)00125-1","article-title":"Fibrosis in hypertensive heart disease: role of the renin-angiotensin-aldosterone system","volume":"88","author":"A Gonzalez","year":"2004","journal-title":"Med Clin North Am"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction","volume":"348","author":"B Pitt","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"F Zannad","year":"2011","journal-title":"N. Engl. J. Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0220837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T14:19:05Z","timestamp":1589033945000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0220837"}},"subtitle":[],"editor":[{"given":"Vincenzo","family":"Lionetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,8,12]]},"references-count":59,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0220837","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,12]]}}}